CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
ABG Update Feature
Chemical Briefing: Chlorantraniliprole Price Surge Tests Generic Manufacturers’ Edge
Chlorantraniliprole’s price spike is exposing generics’ limits, shifting competition...
Industry News
FAO and International Fertilizer Association Renew Partnership to Support Sustainable Agriculture
Third Memorandum of Understanding reinforces cooperation on sustainable nutrient...
ABG Update Feature
Beyond the Science: What Biological Startups Must Do to Win Strategic Partnerships
Industry leaders say validation, scalability, and commercial discipline are...
ABG Update Feature
Price Hike Playbook: Global Crop Protection Leaders Share Strategies for Navigating China Supply and Cost Pressures
Seven global crop protection leaders reveal sourcing, pricing, and...